Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The only thing that would make me happier than a PC at Notre Dame would be seeing Kim on a KBLB Super Bowl commercial. Now that would be some kind of IR.
Really? Are you saying that KBLB stock is fairly priced until something is sold? Potential investors, looking at all the positives that continue to come out in publications, will not commit investment of .08 per share?
The entire market is a gamble, the risk/reward of KBLB increasingly favors the latter. If potential investors wait for something to be sold, the gamble involved for the sake of huge profit will be gone.
We are stuck here because the stock is manipulated, and until new investment blows thru the pps we will continue to be regardless of the news.
If Kim is planning on purchasing a new lab, manufacturing co., etc. then he'd better find a way to raise the pps or dilution of KBLB stock could be huge.
Very positive post, Zinc, hope it's all true.
Could one reason for the failure of Monster silk commercialization, be the realization by Kim and/or potential buyers that the progressing science would soon make it obsolete?
I thought a part of Fraser's interview that was interesting was if the fabric wasn't penetrated, even though the bullet did enter the body, that extraction of the bullet can be made by pulling on the fabric.
We finally agree on something, Lucky, I'd give your left n t also.
Do you think KBLB has run physical tests to determine effectiveness of monster silk in body armor? If so, and results were positive, why wasn't it presented on the net with credit going to KBLB? Three weeks ago it would have been huge as far as establishing KBLB as the leader in this technology instead of competing with goats and bacteria for market attention.
You're right, the news is spreading, but it only makes Ben's job more difficult to keep KBLB out of it.
It would be GREAT to have a product to sell, but new investment thus a higher pps. depends NOW on the increasing probability of the continued success of KBLB. When the means to inform the public on this increasing probability that KBLB is going to succeed is wasted then the pps will remain artificially low.
IMO the pps should be stable in the .20s right now if IR had used successes, such as the platform worm, to build market awareness that would now have been bolstered by the peer review. Now what you have is flippers and others manipulating the pps, instead of new investors building a solid base.
I really don't understand the reasoning that considers any rise in the pps only temporary, accurate and responsible IR work that attracts new investment is the only way to build a solid base for the pps but also to eliminate those that are keeping the pps so low.
Are you saying the peer review was a pump, or the platform worm, or any other success accomplished by KBLB? For KBLB to take advantage of these accomplishments isn't pumping the stock, it's the only way to increase name recognition and investment by presenting KBLB as a viable penny stock with huge potential.
The recent media interest in only one potential product, body armor, presented KBLB with a perfect scenario to build upon the peer review with IR that simply introduced KBLB to the market with, once again FREE, and unsolicited publicity.
"DO NOT OVER ESTIMATE THE IMPORTANCE OF IR."
Are you kidding? KBLB's basic science confirmed by peer review, with the interest shown by media, and yet nothing done by IR to take advantage of this FREE publicity. PPS drops, media interest fades, with investors left to wonder why the silence from KBLB.
You may think IR is not important, but it's failure to take advantage of the peer review to increase KBLB name recognition in the market was a huge mistake. Proposed PC at Notre Dame was dismissed by posters as detrimental to KBLB, now the peer review is proving to be inconsequential to the market even though it confirms the most important aspect of KBLB.
Science proven, potential commercial uses unlimited, associated with Notre Dame, media interest, all adds up to increased market investment and yet the pps continues to fall.
DO NOT UNDER ESTIMATE THE IMPORTANCE OF IR!
Wish I had the money to buy more shares, by their recent actions it apppears TPIV is confident of their success in the on-going clinical trials.
We can't have both?
Regardless of the process amsilk uses, their IR is a heck of a lot more effective than KBLBs.
I'm not being combative, just wanted to know exactly what KBLB can now produce.
Could we produce the silk to make body armor right now that's better the norm, or parachutes, or any of the potential products that have been discussed?
If the science stopped right now, what would KBLB be looking at as far as commercial products are concerned?
What about that product, Zinc, if the progress of the science stopped with what was verified in the peer review?
What commercial products could we expect to come from that original science?
I invested in KBLB for many reasons, not the least being the HUGE potential of commercial products. Also, the first-class advisory board and with the work being done at Notre Dame, there seemed to be nothing but an upside to KBLB as long as the science involved was viable.
Since then, over a year ago, we've seen rapid advancement in the original science which has since been qualified by peer review. We've had media interest almost unheard of in penny stocks. Everything points toward potential investors climbing over each other to buy shares before the risk/reward becomes so overwhelming that a major company commits to buy KBLB.
Question is, why is there no new investment? Why is the pps sooo low? Why are there so many satisfied with the value of KBLB?
KBLB was handed a golden opportunity to present to the world, with FREE publicity, exactly what the potential of this science has to offer in the way of commercial products.
With the announcement of the peer review, most of the media interest was centered on body armor. KBLB's involvement was barely mentioned, if at all, and that is reflected in the lack of interest in the market.
What a waste.
Well, now that's an idea long overdue.
"Nothing like free publicity"
Really? Wouldn't a PC at Notre Dame fit into that category? After a year of accomplishments in the lab, building on the science of the peer review just released and the interest shown by the media, the fact KBLB DID NOT take advantage of that free publicity wasn't lost on the market.
Well, thank goodness the next peer review won't be done until next year, I don't think KBLB could survive another positive review of their science.
Doesn't take much DD to realize that yes, we did miss a cut off or something. We have a penny stock that was presented with an almost unheard of opportunity to take advantage of the public interest in the potential of KBLB products.
We HAD the attention of the public, we HAD the chance to raise name recognition of KBLB in the market. Free nationwide publicity based on facts, doesn't get any better than that for a penny stock, yet except for a initial PR there has been silence from IR.
The only explanation for this lack of IR is that "HUGE" news is coming from the CC, nothing less could explain the strategy of IR to refrain from taking advantage of this rare opportunity.
Hopefully this interest in body armor being made of spidersilk leads to the name recognition that KBLB has long deserved in the market.
Most of the news has been about body armor, but the vast potential commercial uses of KBLB products will be the impetus to put this stock square in the sights of the market.
I hope this interest doesn't "die on the vine" along with the platform worm, etc., this publicity is huge and should be exploited to the full extent by IR.
This article popped up on my computer as one of the 3 top current news stories. Too bad there's no mention of KBLB, free publicity and all that.
Who would have guessed that with all the successes of the lab, along with this peer review and the increased public interest, that the pps of KBLB would continue to be so low. Too bad potential investors in the market have to search to find KBLB's involvement, keeping a low, low profile must be a main part of our IR strategy.
Upcoming PR and CC had better be good.
Well, I hope you're right. But if those tremendous PR and CC don't live up to expectations, then KBLB stock is going to dive.
There is no reason that IR failed to capitalize on the recent peer review, especially when the science has successfully progressed beyond what was published. All of the news articles I've seen barely mention KBLB, if at all.
If Kim presents a business deal or some other sort of commercial plans that the market responds to with the kind of investment KBLB needs, then great. But if he doesn't, and KBLB has let the recent news just die on the vine along with the platform worm, etc., then it has missed a huge opportunity to take advantage of the interest that the media has shown in spidersilk since the review became public.
Thanks for replying, danny, I thought maybe I was the last one holding any stock with the lack of posts on this site. I agree with everything you said, so now it's just a waiting game until the success or failure of the science in clinical trials are determined.
If the trials are successful, this stock would go up so fast that the average investors wouldn't be able to get in under several dollars a share. Who knows were the market value would end up, but it would be very, very, very, high.
Hope so, King, but it's going to take more than just a mild interest to get thru those investors that dump shares for a .01 gain, much less whatever other manipulations are happening.
That sucking sound you hear is the market interest in KBLB going south.
KBLB who?
Stock patterns here aren't going to matter much, if this science proves valid thru ongoing clinical trials then this stock will skyrocket.
Does anyone have any update on those trials, such as the timeline for completion or initial results?
I like it!
I certainly hope he does hit a home run, but he's swinging with 2 strikes already and may have to swing at any pitch that looks halfway decent.
I really hope the pps doesn't affect any deals that Kim may make, but a company with a pps of .20 or .30 is in a far stronger position than one with .08 or .09 and falling.
The remedy for the point I made may have passed us by, that being IR work that took advantage of the peer review to increase name recognition in the market, thus attracting new investment resulting in a rising pps.
As far as selling KBLB stock goes, it just doesn't seem right that those forced to sell must do so at such a low pps. Doesn't seem enough to just say "yes it is sad they are forced to sell" when the stock they counted on for retirement, etc. continues to lose value for NO foreseeable reason other than incompetence and/or greed of a few.
"Thanks for reminding people, it apparently is not obvious to everyone"
Thanks for what? Reminding people of what has been obvious for the past year, that being Kim could sign a deal at any time. So now we're suppose to accept the pps as we wait hopefully for a deal with Dow?
People are forced to sell KBLB everyday for a variety of reasons, even if they believe it will be the next Microsoft. Just a shame they can't realize at least some of the profits hoped for, not when the pps is so low. And by saying that I guess I am truly UNBELIEVABLE.
Don't tell me what we don't have, tell potential investors what we do have. The only negative waves a potential investor would get from these posts is from those than continually downplay KBLB's successes, not from those that question why the pps is so low.
Name recognition brings DD, where potential investors both large and small, can decide whether the incredible upside of KBLB is worth investing in.
We DON'T need a commercial contract to attract investment, only the science and a good business plan which certainly includes better IR. This is a penny stock with break-thru science that appears to be valid, with innumerable commercial products possible. Don't know many investors that wouldn't take a second look at such a company, especially when the pps could rise significantly at any time.
Out of the dark and into the light, let the world know what KBLB is striving to accomplish.
If all that is true, then there is more reason than ever for Kim to do anything possible to increase KBLB's pps. Control of this pps, no matter by whom, can happen only with a lack of market interest and if we have one thing, it's that.
Why all the arguments explaining the low pps.? That Kim has to accept dealing from a weak position caused by the low pps? Doesn't anyone have any suggestions on what to do to raise it other than "huge" news in the CC that will force market interest?
Bottom line, the peer review qualified the science. That alone makes KBLB's risk/reward ratio swing decisively toward investing, much less the successes such as the platform worm that have improved upon the science.
NAME RECOGNITION!!! Without it, KBLB could create a exact clone of 4fatcat4 and the pps would still remain the same.
What I don't understand is how both mojo's and manshoon's arguments that a higher pps was attainable with better IR somehow labels them as having "negative waves". A argument that KBLB stock should have a higher pps should be viewed as nothing but positive, to do nothing is to accept the will of the few.
Are you saying long term investors shouldn't be concerned with a low pps for the foreseeable future? That we should be satisfied with KBLB's future dilution of shares when it borrows operating capital at .07 rather than a pps of .20 or higher.
The lower the pps the less options are open to Kim, especially if he is concerned with dilution of KBLB stock, and that's how Kim needed CSC in the past.
I agree, KBLB isn't going to lose this one because it's IR failed to "optimize", but it may cost us long term investors either a massive dilution of shares or a mediocre business deal.
"This pps is at the low end of the value, .11 is at the high end."
I guess the question is why so low? You have a company, albeit a penny, that is successfully developing a science whose potential commercial ramifications are limited simply by how far the science eventually develops. The science is being developed at the prestigious ND university, and has been supported by peer review. On top of that, news could be made at any time of commercial dealings that would skyrocket the pps.
So I ask again, why so low? What am I missing that is preventing potential investors from investing after evaluating the risk/reward of investment in KBLB?
I agree, it's adding up to just another opportunity lost by the IR dept. Seems ND's local media are excited by the news that these scientific breakthru's are taking place, but just not KBLB.
I assume most on this board are aware of my feelings toward the lack of both name recognition and general public knowledge of KBLB's potential. This latest news, more or less proving the success of the science, should have justified to most potential investors the huge gains that could be made from investment in KBLB. Think maybe this announcement at a ND PC, along with all of KBLB's accomplishments building on that news, wouldn't have made the market take notice?
I don't know what's going on, but it seems to me those that have the most to gain by a low pps are the ones with the most influence with KBLB. Many were quick to give Ben credit for the news, yet now the pps is falling and we're being told to wait for a CC that should have been held already.
If Kim, Ben, and the blue ribbon advisory panel are all working together and will present at the CC news of a sale or something else that is
"huge", then KBLB's reluctance to take advantage of this recent news is justified. If not, then we missed a great opportunity to attract massive new investment.
I'm sorry but I really don't understand how the CSC deal works.
Is the stock being offered in return for operating capital have a set price or is the amount of stock dependent on the current pps?